The Nike-Adidas battle hasn’t been much a fight in recent quarters. Nike, the world’s best-selling sneaker brand, has stumbled badly in North America in recent quarters as its designers have missed shifts in fashion and traditional retail chains, where the Beaverton, Ore., company had more to lose, have suffered. In fact, North America sales for...
NYS Entity Status
NYS Filing Date
JUNE 27, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2013 - BEST BRANDS SALES COMPANY, LLC
Around the Web
- Nike sales sag as Adidas continues to soar
By Richard Morgan - Thursday Sep 28, 2017
- Dan Loeb buys a chunk of Nestle, blasts ‘staid’ culture
By Carleton English - Monday Jun 26, 2017
Dan Loeb just placed his biggest bet ever on a chocolate company. The activist investor’s hedge fund Third Point LLC amassed a $3.5 billion stake in Nestle, the world’s largest packaged foods company, representing roughly 1.25 percent of the Swiss-based company’s shares. Loeb is hoping to reinvigorate the brand amid changing food tastes as well...
- Longtime hockey exec rebrands himself as activist investor
By Josh Kosman - Tuesday Jul 25, 2017
Longtime hockey executive Graeme Roustan, who lately has been re-branding himself as a shareholder activist, has succeeded at pushing pharmaceutical company Aeterna Zentaris to explore a sale, The Post has learned. Roustan — best known for his stint as chairman of Performance Sports Group, maker of Bauer hockey sticks — confirmed to The Post he...
- Best Buy warns strong sales are not the ‘new normal’
By Reuters - Tuesday Aug 29, 2017
Best Buy, the No. 1 US consumer electronics retailer, reported a much stronger than expected rise in quarterly same-store sales on Tuesday, but warned that the performance should not be seen as a “new normal.” The company’s shares, which jumped more than 5 percent before the bell, fell 8.5 percent in early trading. The stock...
- Pfizer considers sale of consumer brands
By Associated Press - Tuesday Oct 10, 2017
Pfizer may be done selling ChapStick, Advil, Robitussin and other brands that people can buy without a prescription. The pharmaceutical giant is weighing options for its consumer health care business. It may spin off or sell the unit, which also produces Preparation H and the Centrum brand of vitamins. Pfizer may also leave the business as is, with no sale. The New York drugmaker expects any decisions on the business to be made next year. Chairman and CEO Ian Read said Tuesday that the over-the-counter medications and consumer health products are distinct enough from the company’s main biopharmaceutical business that its value might be “more fully realized” outside the company.
- The Top 10 Moments of New York Fashion Week
By THE NEW YORK TIMES - Friday Sep 15, 2017
Highlights from the shows, including a celebrity-packed front row at Calvin Klein and a trek to Bedford Hills, N.Y., to see Ralph Lauren’s vintage cars.